Oncogenic Ras blocks anoikis by activation of a novel effector pathway independent of phosphatidylinositol 3-kinase

Molecular and Cellular Biology

Volumn 21, Issue 16, 2001, Pages 5488-5499

  McFall, A ^a   Ulku A ^a   Lambert, Q T ^a   Kusa, A ^a   Rogers Graham, K ^a   Der, C J ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; RAF PROTEIN; RAS PROTEIN;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CELL DEATH; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN DOMAIN;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANOIKIS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENES, RAS; RATS; SIGNAL TRANSDUCTION;

EID: 0034928862     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.16.5488-5499.2001     Document Type: Article

References (59)

1. ras genes
2. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression
3. Characterization of an epithelioid cell line derived from the rat small intestine
4. ras oncogenes in human cancer: A review
5. MEK/ERK signaling pathway regulates the expression of bcl-2, bcl-X(L), and mcl-1 and promotes survival of human pancreatic cancer cells
6. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix
7. Increasing complexity of Ras signaling
8. The regulation of anoikis: MEKK-1 activation requires cleavage by caspases
9. Biological assays for Ras transformation
10. Oncogenic activation of Ras proteins
11. R-Ras induces malignant, but not morphologic, transformation of NIH3T3 cells
12. Mechanisms and consequences of activation of protein kinase B/Akt
13. Identification of a novel inhibitor of mitogen-activated protein kinase kinase
14. An interleukin-1 beta-converting enzyme-like protease is a common mediator of apoptosis in thymocytes
15. Evidence for a Ras/Ral signaling cascade
16. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase
17. Disruption of epithelial cell-matrix interactions induces apoptosis
18. Integrins and anoikis
19. A specific inhibitor of the epidermal growth factor receptor tyrosine kinase
20. A Raf-independent epidermal growth factor receptor autocrine loop is necessary for Ras transformation of rat intestinal epithelial cells
21. TC21 causes transformation by Raf-independent signaling pathways
22. Creation of human tumour cells with defined genetic elements
23. Regulation of cell number in the mammalian gastrointestinal tract: The importance of apoptosis
24. Protein binding and signaling properties of RIN1 suggest a unique effector function
25. Suppression of Fas/APO-1-mediated apoptosis by mitogen-activated kinase signaling
26. R-Ras is regulated by activators and effectors distinct from those that control Ras function
27. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation
28. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation
29. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway
30. Direct control of the Forkhead transcription factor AFX by protein kinase B
31. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane
32. The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal
33. Ras effectors
34. R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways
35. Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells
36. Ras, but not Src, transformation of RIE-1 epithelial cells is dependent on activation of the mitogen-activated protein kinase cascade
37. Production of high-titer helper-free retroviruses by transient transfection
38. Activation of the nuclear factor-KB by Rho, CDC42, and Rac-1 proteins
39. Differentiation and cancer in the mammary gland: Shedding light on an old dichotomy
40. Apoptosis in human skin development: Morphogenesis, periderm, and stem cells
41. A role for RalGDS and a novel Ras effector in the Ras-mediated inhibition of skeletal myogenesis
42. Phosphatidylinositol-3-OH kinase as a direct target of Ras
43. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras
44. Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation
45. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling
46. Downregulation of the pro-apoptotic protein Bak is required for the ras-induced transformation of intestinal epithelial cells
47. Activated Ras prevents downregulation of Bcl-X(L) triggered by detachment from the extracellular matrix. A mechanism of Ras-induced resistance to anoikis in intestinal epithelial cells
48. Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase
49. Integrins, oncogenes, and anchorage independence
50. INK4a
51. Understanding Ras: "It ain't over 'til it's over."
52. Definition of the human raf amino-terminal regulatory region by deletion mutagenesis
53. racl regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-κB activation
54. Ral-GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation
55. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)
56. Multiple Ras functions can contribute to mammalian cell transformation
57. Ras caught in another affair: The exchange factors for Ral
58. Stimulation of gene induction and cell growth by the Ras effector Rlf
59. Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase